Skip to content

IDENIX PHARMACEUTICALS INC

Delisted

CIK 1093649fmd_060X0KY45TNAG8Y0H89DAE86YDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2014, 18 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012FY2013
Total revenues13107–0
Cost of revenue23231
Gross profit1075–(0)
Research and development4245417084
Operating income(54)(63)(53)(35)(124)
Other non-operating income (expense)11131
Income before taxes(53)(62)(52)(32)(122)
Income tax expense0(0)(0)(0)(0)
Net income from continuing operations(53)(62)(52)(32)(122)
Net income(53)(62)(52)(32)(122)
IDENIX PHARMACEUTICALS INC financial statements · FinancialMD